LOOMIS SAYLES & CO L P – Halozyme Therapeutics, Inc. Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$84.94M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.11% | -24.20K shares | -10.64M | $39.54 | 2.14M |
| Q2 2022 | share | Decrease | -0.59% | -12.79K shares | 8.44M | $44 | 2.17M |
| Q1 2022 | share | Increase | +13.36% | 257.53K shares | 9.63M | $39.88 | 2.18M |
| Q4 2021 | share | Decrease | -2.15% | -42.31K shares | -2.62M | $40.32 | 1.92M |
| Q3 2021 | share | Decrease | -0.26% | -5.13K shares | -9.55M | $40.68 | 1.97M |
| Q2 2021 | share | Decrease | -0.31% | -6.06K shares | 7.09M | $45.41 | 1.97M |
| Q1 2021 | share | Decrease | -0.19% | -3.77K shares | -2.18M | $41.69 | 1.98M |
| Q4 2020 | share | Increase | +37.20% | 538.17K shares | 46.75M | $42.71 | 1.98M |
| Q3 2020 | share | Increase | +1.94% | 27.51K shares | -28K | $26.28 | 1.44M |
| Q2 2020 | share | Increase | +9.52% | 123.33K shares | 14.73M | $26.81 | 1.41M |
| Q1 2020 | share | Increase | +0.63% | 8.05K shares | 480K | $17.99 | 1.29M |
| Q4 2019 | share | Decrease | -0.33% | -4.21K shares | 2.79M | $17.73 | 1.28M |
| Q3 2019 | share | Increase | 0.00% | 1.29M shares | 20.04M | $15.51 | 1.29M |